7b, a novel amonafide analog, inhibited proliferation and phorbol 12-myristate 13-acetate/phytohemagglutinin-induced inflammatory responses of Jurkat T cells via p73-dependent pathway and decrease of nuclear factor-κB DNA-binding, respectively

References

• Jemal A, Siegel R, Xu J, . Cancer statistics, 2010. CA Cancer J Clin 2010;60:277–300.
   PubMed Web of Science ®Google Scholar
• Lv M, Xu H. Overview of naphthalimide analogs as anticancer agents. Curr Med Chem 2009;16:4797–4813.
   PubMed Web of Science ®Google Scholar
• Saez R, Craig JB, Kuhn JG, . Phase I clinical investigation of amonafide. J Clin Oncol 1989;7:1351–1358.
   PubMed Web of Science ®Google Scholar
• Berger MZ, Kris MG, Gralla RJ, . Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer. Am J Clin Oncol 1991;14:124–126.
   PubMed Web of Science ®Google Scholar
• Perez RP, Nash SL, Ozols RF, . Phase II study of amonafide in advanced and recurrent sarcoma patients. Invest New Drugs 1992;10:99–101.
   PubMed Web of Science ®Google Scholar
• Chau M, Christensen JL, Ajami AM, . Amonafide, a topoisomerase II inhibitor, is unaffected by P-glycoprotein-mediated efflux. Leuk Res 2008;32:465–473.
   PubMed Web of Science ®Google Scholar
• Ingrassia L, Lefranc F, Kiss R, . Naphthalimides and azonafides as promising anti-cancer agents. Curr Med Chem 2009;16: 1192–1213.
   PubMed Web of Science ®Google Scholar
• Zhu H, Huang M, Yang F, . R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II. Mol Cancer Ther 2007;6:484–495.
   PubMed Web of Science ®Google Scholar
• Liang X, Xu YF, Xu K, . B1, a novel amonafide analogue, overcomes the resistance conferred by Bcl-2 in human promyelocytic leukemia HL60 cells. Mol Cancer Res 2010;8:1619–1632.
   PubMed Web of Science ®Google Scholar
• Chen Z, Liang X, Zhang H, . A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis. J Med Chem 2010;53:2589–2600.
   PubMed Web of Science ®Google Scholar
• Wallace HM, Palmer AJ. The polyamine transport system as a target for anticancer drug development. Amino Acids 2010;38: 415–422.
   PubMed Web of Science ®Google Scholar
• Huang S, Norton JT, Witsch MA, . Synthesis and anticancer activities of 6-amino amonafide derivatives. Anticancer Drugs 2008; 19:23–36.
   PubMed Web of Science ®Google Scholar
• Amundson SA, Myers TG, Fornace AJ Jr.Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 1998;17:3287–3299.
   PubMed Web of Science ®Google Scholar
• Di Cintio A, Di Gennaro E, Budillon A. Restoring p53 function in cancer: novel therapeutic approaches for applying the brakes to tumorigenesis. Recent Pat Anticancer Drug Discov 2010;5:1–13.
   Google Scholar
• Weller M. Predicting response to cancer chemotherapy: the role of p53. Cell Tissue Res 1998;292:435–445.
   PubMed Web of Science ®Google Scholar
• Li T, Hongyo T, Syaifudin M, . Mutations of the p53 gene in nasal NK/T-cell lymphoma. Lab Invest 2000;80:493–499.
   PubMed Web of Science ®Google Scholar
• Moller MB, Gerdes AM, Skjodt K, . Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma. Clin Cancer Res 1999;5:1085–1091.
   PubMed Web of Science ®Google Scholar
• Roomi MW, Bhanap BA, Roomi NW, . Antineoplastic effects of nutrient mixture on Raji And Jurkat T cells: the two highly aggressive non Hodgkin's lymphoma cell lines. Exp Oncol 2009;31:149–155.
   PubMedGoogle Scholar
• Lin B, Chen Z, Xu Y, . 7-b, a novel amonafide analogue, cause growth inhibition and apoptosis in Raji cells via a ROS-mediated mitochondrial pathway. Leuk Res 2011;35:646–656.
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883–899.
   PubMed Web of Science ®Google Scholar
• Lin W-W, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007;117: 1175–1183.
   PubMed Web of Science ®Google Scholar
• Liang X, Wu A, Xu Y, . B1, a novel naphthalimide-based DNA intercalator, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation. Invest New Drugs 2011;29:646–658.
   PubMed Web of Science ®Google Scholar
• Li Y, Shao J, Shen K, . E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest and apoptosis in p53-deficient K562 cells. J Cell Biochem2012 May 16. [Epub ahead of print]
   Google Scholar
• Alhosin M, Abusnina A, Achour M, . Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1. Biochem Pharmacol 2010;79:1251–1260.
   PubMed Web of Science ®Google Scholar
• Jost CA, Marin MC, Kaelin WG Jr.p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature (London) 1997;389:191–194.
   PubMed Web of Science ®Google Scholar
• Bronner C, Achour M, Arima Y, . The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Ther 2007;115:419–434.
   PubMed Web of Science ®Google Scholar
• Gartel AL, Ye X, Goufman E, . Myc represses the p21((WAF1/CIP1)) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci USA 2001;98:4510–4515.
   PubMed Web of Science ®Google Scholar
• Lu HR, Meng LH, Huang M, . DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells. Cancer Chemother Pharmacol 2005;55:286–294.
   PubMed Web of Science ®Google Scholar
• Mah LJ, El-Osta A, Karagiannis TC. gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 2010;24: 679–686.
   PubMed Web of Science ®Google Scholar
• Kang MA, So EY, Simons AL, . DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway. Cell Death Dis 2012;3:e249.
   PubMed Web of Science ®Google Scholar
• Mondal S, Bhattacharya K, Mallick A, . Bak compensated for Bax in p53-null cells to release cytochrome c for the initiation of mitochondrial signaling during Withanolide D-induced apoptosis. PLoS One 2012;7:e34277.
   Web of Science ®Google Scholar
• Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001;107:7–11.
   PubMed Web of Science ®Google Scholar
• Amin AR, Paul RK, Thakur VS, . A novel role for p73 in the regulation of Akt-Foxo1a-Bim signaling and apoptosis induced by the plant lectin, Concanavalin A. Cancer Res 2007;67:5617–5621.
   PubMed Web of Science ®Google Scholar
• Davis PK, Dowdy SF. p73. Int J Biochem Cell Biol 2001;33: 935–939.
   PubMed Web of Science ®Google Scholar
• Oberst A, Rossi M, Salomoni P, . Regulation of the p73 protein stability and degradation. Biochem Biophys Res Commun 2005; 331:707–712.
   PubMed Web of Science ®Google Scholar
• Irwin MS, Kondo K, Marin MC, . Chemosensitivity linked to p73 function. Cancer Cell 2003;3:403–410.
   PubMed Web of Science ®Google Scholar
• Zhu J, Jiang J, Zhou W, . The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res 1998; 58:5061–5065.
   PubMed Web of Science ®Google Scholar
• Jeanblanc M, Mousli M, Hopfner R, . The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle. Oncogene 2005;24: 7337–7345.
   PubMedGoogle Scholar
• Ho JSL, Ma WL, Mao DYL, . p53-dependent transcriptional repression of c-myc is required for G(1) cell cycle arrest. Mol Cell Biol 2005;25:7423–7431.
   PubMed Web of Science ®Google Scholar
• Griesmann H, Schlereth K, Krause M, . p53 and p73 in suppression of Myc-driven lymphomagenesis. Int J Cancer 2009; 124:502–506.
   PubMed Web of Science ®Google Scholar
• Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci 2010;35:505–513.
   PubMed Web of Science ®Google Scholar
• Klein A, Maldonado C, Vargas LM, . Oxidative stress activates the c-Abl/p73 proapoptotic pathway in Niemann-Pick type C neurons. Neurobiol Dis 2011;41:209–218.
   Google Scholar
• Cavigiolio G, Morgan JL, Robinson BH, . Fluorescent sugar and uridine conjugates of 1,8-naphthalimides with methyl and ferrocenyl headgroups. Aust J Chem 2004;57:885–894.
   Web of Science ®Google Scholar
• Philip M, Rowley DA, Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 2004;14:433–439.
   PubMed Web of Science ®Google Scholar
• Schmitz ML, Bacher S, Dienz O. NF-kappaB activation pathways induced by T cell costimulation. FASEB J 2003;17:2187–2193.
   PubMed Web of Science ®Google Scholar